A Transgenic Rat Model of Charcot-Marie-Tooth Disease

Sereda, Michael; Griffiths, Ian; Pühlhofer, Anja; Stewart, Helen; Rossner, Moritz J; Zimmermann, Frank; Magyar, Josef P; Schneider, Armin; Hund, Ernst; Meinck, Hans-Michael; Suter, Ueli; Nave, Klaus-Armin

doi:10.1016/S0896-6273(00)80128-2

Datensatz

DATENSATZ AKTIONENEXPORT

Zur Ablage hinzufügen

Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben

Zeitschriftenartikel

A Transgenic Rat Model of Charcot-Marie-Tooth Disease

MPG-Autoren

/persons/resource/persons182320

Nave, Klaus-Armin
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

Externe Ressourcen

Es sind keine externen Ressourcen hinterlegt

Volltexte (beschränkter Zugriff)

Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.

Volltexte (frei zugänglich)

Es sind keine frei zugänglichen Volltexte in PuRe verfügbar

Ergänzendes Material (frei zugänglich)

Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar

Zitation

Sereda, M., Griffiths, I., Pühlhofer, A., Stewart, H., Rossner, M. J., Zimmermann, F., et al. (1996). A Transgenic Rat Model of Charcot-Marie-Tooth Disease. Neuron, 16(5), 1049-1060. doi:10.1016/S0896-6273(00)80128-2.

Zitierlink: https://hdl.handle.net/21.11116/0000-000D-1F58-F

Zusammenfassung

Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy in humans and has been associated with a partial duplication of chromosome 17 (CMT type 1A). We have generated a transgenic rat model of this disease and provide experimental evidence that CMT1A is caused by increased expression of the gene for peripheral myelin protein-22 (PMP22, gas-3). PMP22-transgenic rats develop gait abnormalities caused by a peripheral hypomyelination, Schwann cell hypertrophy (onion bulb formation), and muscle weakness. Reduced nerve conduction velocities closely resemble recordings in human patients with CMT1A. When bred to homozygosity, transgenic animals completely fail to elaborate myelin. We anticipate that the CMT rat model will facilitate the identification of a cellular disease mechanism and serve in the evaluation of potential treatment strategies.